Vitiligo Repigmentation Achieved in Five Treatments with XTRAC Excimer Laser, Study Suggests
STRATA Skin Sciences Inc announces the publication of an independent study on the treatment of vitiligo using the Company’s XTRAC excimer laser.
STRATA Skin Sciences Inc announces the publication of an independent study on the treatment of vitiligo using the Company’s XTRAC excimer laser.
The multicenter trial showed the combination therapy offered superior efficacy, rapid repigmentation, and a strong safety profile compared to monotherapy.
Cutera has launched Global Laser Aesthetics Month this October to spotlight laser technology, skin diversity, and provider and patient education.
USA: Topical tofacitinib 2% is effective for the treatment of refractory vitiligo, suggests a recent study published in the British Journal of Dermatology, Specialty Medical Dialogues reports.
Read MoreMicroneedling combined with topical 5-fluorouracil (5-FU) outperformed microneedling alone in the treatment of vitiligo, according to the results of a study, Dermatology Advisor reports.
Read MoreTeVido BioDevices (TeVido) announces the commercial availability of its lead product TruPigment (autologous non-cultured epidermal cell suspension) for the restoration of lost skin color due to vitiligo.
Read MoreCohort study data published in the Journal of the American Academy of Dermatology identifies multiple new disease associations with vitiligo, including multiple sclerosis, idiopathic thrombocytopenic purpura (ITP), and lymphoma.
Read MoreA nationwide phase II clinical trial, coordinated out of Tufts Medical Center in Boston, has found that a topical cream was extremely effective in reversing the effects of vitiligo, a relatively common autoimmune disease that causes loss of skin pigmentation.
Read More